3.10.0.1 html 202 299 1 true 79 0 false 6 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://elitepharma.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - Condensed Consolidated Balance Sheets Sheet http://elitepharma.com/role/BalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://elitepharma.com/role/BalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://elitepharma.com/role/StatementsOfOperations Condensed Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Consolidated Statements of Shareholders??? Equity (unaudited) Sheet http://elitepharma.com/role/StatementsOfShareholdersEquity Consolidated Statements of Shareholders??? Equity (unaudited) Statements 5 false false R6.htm 00000006 - Statement - Consolidated Statements of Cash Flows (unaudited) Sheet http://elitepharma.com/role/StatementsOfCashFlows Consolidated Statements of Cash Flows (unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - Summary of Significant Accounting Policies Sheet http://elitepharma.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 7 false false R8.htm 00000008 - Disclosure - Inventory Sheet http://elitepharma.com/role/Inventory Inventory Notes 8 false false R9.htm 00000009 - Disclosure - Property and Equipment, Net Sheet http://elitepharma.com/role/PropertyAndEquipmentNet Property and Equipment, Net Notes 9 false false R10.htm 00000010 - Disclosure - Intangible Assets Sheet http://elitepharma.com/role/IntangibleAssets Intangible Assets Notes 10 false false R11.htm 00000011 - Disclosure - Njeda Bonds Sheet http://elitepharma.com/role/NjedaBonds Njeda Bonds Notes 11 false false R12.htm 00000012 - Disclosure - Loans Payable Sheet http://elitepharma.com/role/LoansPayable Loans Payable Notes 12 false false R13.htm 00000013 - Disclosure - Related Party Secured Promissory Note with Mikah Pharma LLC Sheet http://elitepharma.com/role/RelatedPartySecuredPromissoryNoteWithMikahPharmaLlc Related Party Secured Promissory Note with Mikah Pharma LLC Notes 13 false false R14.htm 00000014 - Disclosure - Deferred Revenue Sheet http://elitepharma.com/role/DeferredRevenue Deferred Revenue Notes 14 false false R15.htm 00000015 - Disclosure - Commitments and Contingencies Sheet http://elitepharma.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 15 false false R16.htm 00000016 - Disclosure - Mezzanine Equity Sheet http://elitepharma.com/role/MezzanineEquity Mezzanine Equity Notes 16 false false R17.htm 00000017 - Disclosure - Derivative Financial Instruments - Warrants Sheet http://elitepharma.com/role/DerivativeFinancialInstrumentsWarrants Derivative Financial Instruments - Warrants Notes 17 false false R18.htm 00000018 - Disclosure - Shareholders' Equity Sheet http://elitepharma.com/role/ShareholdersEquity Shareholders' Equity Notes 18 false false R19.htm 00000019 - Disclosure - Stock-Based Compensation Sheet http://elitepharma.com/role/StockBasedCompensation Stock-Based Compensation Notes 19 false false R20.htm 00000020 - Disclosure - Concentrations and Credit Risk Sheet http://elitepharma.com/role/ConcentrationsAndCreditRisk Concentrations and Credit Risk Notes 20 false false R21.htm 00000021 - Disclosure - Segment Results Sheet http://elitepharma.com/role/SegmentResults Segment Results Notes 21 false false R22.htm 00000022 - Disclosure - Collaborative Agreement with Epic Pharma LLC Sheet http://elitepharma.com/role/CollaborativeAgreementWithSungenPharmaLlc Collaborative Agreement with Epic Pharma LLC Notes 22 false false R23.htm 00000023 - Disclosure - Collaborative Agreement with Sungen Pharma LLC Sheet http://elitepharma.com/role/CollaborativeAgreementWithSungenPharmaLLC Collaborative Agreement with Sungen Pharma LLC Notes 23 false false R24.htm 00000024 - Disclosure - Related Party Transaction Agreements With Epic Pharma LLC Sheet http://elitepharma.com/role/RelatedPartyTransactionAgreementsWithEpicPharmaLlc Related Party Transaction Agreements With Epic Pharma LLC Notes 24 false false R25.htm 00000025 - Disclosure - Manufacturing, License and Development Agreements Sheet http://elitepharma.com/role/ManufacturingLicenseAndDevelopmentAgreements Manufacturing, License and Development Agreements Notes 25 false false R26.htm 00000026 - Disclosure - Related Party Agreements With Mikah Pharma LLC Sheet http://elitepharma.com/role/RelatedPartyAgreementsWithMikahPharmaLlc1 Related Party Agreements With Mikah Pharma LLC Notes 26 false false R27.htm 00000027 - Disclosure - Subsequent Events Sheet http://elitepharma.com/role/SubsequentEvents Subsequent Events Notes 27 false false R28.htm 00000028 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://elitepharma.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://elitepharma.com/role/SummaryOfSignificantAccountingPolicies 28 false false R29.htm 00000029 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://elitepharma.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://elitepharma.com/role/SummaryOfSignificantAccountingPolicies 29 false false R30.htm 00000030 - Disclosure - Inventory (Tables) Sheet http://elitepharma.com/role/InventoryTables Inventory (Tables) Tables http://elitepharma.com/role/Inventory 30 false false R31.htm 00000031 - Disclosure - Property and Equipment, Net (Tables) Sheet http://elitepharma.com/role/PropertyAndEquipmentNetTables Property and Equipment, Net (Tables) Tables http://elitepharma.com/role/PropertyAndEquipmentNet 31 false false R32.htm 00000032 - Disclosure - Intangible Assets (Tables) Sheet http://elitepharma.com/role/IntangibleAssetsTables Intangible Assets (Tables) Tables http://elitepharma.com/role/IntangibleAssets 32 false false R33.htm 00000033 - Disclosure - Njeda Bonds (Tables) Sheet http://elitepharma.com/role/NjedaBondsTables Njeda Bonds (Tables) Tables http://elitepharma.com/role/NjedaBonds 33 false false R34.htm 00000034 - Disclosure - Loans Payable (Tables) Sheet http://elitepharma.com/role/LoansPayableTables Loans Payable (Tables) Tables http://elitepharma.com/role/LoansPayable 34 false false R35.htm 00000035 - Disclosure - Mezzanine Equity (Tables) Sheet http://elitepharma.com/role/MezzanineEquityTables Mezzanine Equity (Tables) Tables http://elitepharma.com/role/MezzanineEquity 35 false false R36.htm 00000036 - Disclosure - Derivative Financial Instruments - Warrants (Tables) Sheet http://elitepharma.com/role/DerivativeFinancialInstrumentsWarrantsTables Derivative Financial Instruments - Warrants (Tables) Tables http://elitepharma.com/role/DerivativeFinancialInstrumentsWarrants 36 false false R37.htm 00000037 - Disclosure - Stock-Based Compensation (Tables) Sheet http://elitepharma.com/role/StockBasedCompensationTables Stock-Based Compensation (Tables) Tables http://elitepharma.com/role/StockBasedCompensation 37 false false R38.htm 00000038 - Disclosure - Segment Results (Tables) Sheet http://elitepharma.com/role/SegmentResultsTables Segment Results (Tables) Tables http://elitepharma.com/role/SegmentResults 38 false false R39.htm 00000039 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://elitepharma.com/role/SummaryOfSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://elitepharma.com/role/SummaryOfSignificantAccountingPoliciesTables 39 false false R40.htm 00000040 - Disclosure - Summary of Significant Accounting Policies (Details 1) Sheet http://elitepharma.com/role/SummaryOfSignificantAccountingPoliciesDetails1 Summary of Significant Accounting Policies (Details 1) Details http://elitepharma.com/role/SummaryOfSignificantAccountingPoliciesTables 40 false false R41.htm 00000041 - Disclosure - Summary of Significant Accounting Policies (Details 2) Sheet http://elitepharma.com/role/SummaryOfSignificantAccountingPoliciesDetails2 Summary of Significant Accounting Policies (Details 2) Details http://elitepharma.com/role/SummaryOfSignificantAccountingPoliciesTables 41 false false R42.htm 00000042 - Disclosure - Summary of Significant Accounting Policies (Details Textual) Sheet http://elitepharma.com/role/SummaryOfSignificantAccountingPoliciesDetailsTextual Summary of Significant Accounting Policies (Details Textual) Details http://elitepharma.com/role/SummaryOfSignificantAccountingPoliciesTables 42 false false R43.htm 00000043 - Disclosure - Inventory (Details) Sheet http://elitepharma.com/role/InventoryDetails Inventory (Details) Details http://elitepharma.com/role/InventoryTables 43 false false R44.htm 00000044 - Disclosure - Property and Equipment, Net (Details) Sheet http://elitepharma.com/role/PropertyAndEquipmentNetDetails Property and Equipment, Net (Details) Details http://elitepharma.com/role/PropertyAndEquipmentNetTables 44 false false R45.htm 00000045 - Disclosure - Property and Equipment, Net (Details Textual) Sheet http://elitepharma.com/role/PropertyAndEquipmentNetDetailsTextual Property and Equipment, Net (Details Textual) Details http://elitepharma.com/role/PropertyAndEquipmentNetTables 45 false false R46.htm 00000046 - Disclosure - Intangible Assets (Details) Sheet http://elitepharma.com/role/IntangibleAssetsDetails Intangible Assets (Details) Details http://elitepharma.com/role/IntangibleAssetsTables 46 false false R47.htm 00000047 - Disclosure - Njeda Bonds (Details) Sheet http://elitepharma.com/role/NjedaBondsDetails Njeda Bonds (Details) Details http://elitepharma.com/role/NjedaBondsTables 47 false false R48.htm 00000048 - Disclosure - Njeda Bonds (Details Textual) Sheet http://elitepharma.com/role/NjedaBondsDetailsTextual Njeda Bonds (Details Textual) Details http://elitepharma.com/role/NjedaBondsTables 48 false false R49.htm 00000049 - Disclosure - Loans Payable (Details) Sheet http://elitepharma.com/role/LoansPayableDetails Loans Payable (Details) Details http://elitepharma.com/role/LoansPayableTables 49 false false R50.htm 00000050 - Disclosure - Loans Payable (Details Textual) Sheet http://elitepharma.com/role/LoansPayableDetailsTextual Loans Payable (Details Textual) Details http://elitepharma.com/role/LoansPayableTables 50 false false R51.htm 00000051 - Disclosure - Related Party Secured Promissory Note With Mikah Pharma LLC (Details) Sheet http://elitepharma.com/role/RelatedPartySecuredPromissoryNoteWithMikahPharmaLlcDetails Related Party Secured Promissory Note With Mikah Pharma LLC (Details) Details 51 false false R52.htm 00000052 - Disclosure - Deferred Revenue (Details) Sheet http://elitepharma.com/role/DeferredRevenueDetailsTextual Deferred Revenue (Details) Details http://elitepharma.com/role/DeferredRevenue 52 false false R53.htm 00000053 - Disclosure - Commitments and Contingencies (Details) Sheet http://elitepharma.com/role/CommitmentsAndContingenciesDetails Commitments and Contingencies (Details) Details http://elitepharma.com/role/CommitmentsAndContingencies 53 false false R54.htm 00000054 - Disclosure - Mezzanine Equity (Details) Sheet http://elitepharma.com/role/MezzanineEquityDetails Mezzanine Equity (Details) Details http://elitepharma.com/role/MezzanineEquityTables 54 false false R55.htm 00000055 - Disclosure - Mezzanine Equity (Details 1) Sheet http://elitepharma.com/role/MezzanineEquityDetails1 Mezzanine Equity (Details 1) Details http://elitepharma.com/role/MezzanineEquityTables 55 false false R56.htm 00000056 - Disclosure - Mezzanine Equity (Details Textual) Sheet http://elitepharma.com/role/MezzanineEquityDetailsTextual Mezzanine Equity (Details Textual) Details http://elitepharma.com/role/MezzanineEquityTables 56 false false R57.htm 00000057 - Disclosure - Derivative Financial Instruments - Warrants (Details) Sheet http://elitepharma.com/role/DerivativeFinancialInstrumentsWarrantsDetails Derivative Financial Instruments - Warrants (Details) Details http://elitepharma.com/role/DerivativeFinancialInstrumentsWarrantsTables 57 false false R58.htm 00000058 - Disclosure - Derivative Financial Instruments - Warrants (Details 1) Sheet http://elitepharma.com/role/DerivativeFinancialInstrumentsWarrantsDetails1 Derivative Financial Instruments - Warrants (Details 1) Details http://elitepharma.com/role/DerivativeFinancialInstrumentsWarrantsTables 58 false false R59.htm 00000059 - Disclosure - Derivative Financial Instruments - Warrants (Details 2) Sheet http://elitepharma.com/role/DerivativeFinancialInstrumentsWarrantsDetails2 Derivative Financial Instruments - Warrants (Details 2) Details http://elitepharma.com/role/DerivativeFinancialInstrumentsWarrantsTables 59 false false R60.htm 00000060 - Disclosure - Derivative Financial Instruments - Warrants (Details Textual) Sheet http://elitepharma.com/role/DerivativeFinancialInstrumentsWarrantsDetailsTextual Derivative Financial Instruments - Warrants (Details Textual) Details http://elitepharma.com/role/DerivativeFinancialInstrumentsWarrantsTables 60 false false R61.htm 00000061 - Disclosure - Shareholders??? Equity (Details) Sheet http://elitepharma.com/role/ShareholdersEquityDetailsTextual Shareholders??? Equity (Details) Details 61 false false R62.htm 00000062 - Disclosure - Stock-Based Compensation (Details) Sheet http://elitepharma.com/role/StockBasedCompensationDetails Stock-Based Compensation (Details) Details http://elitepharma.com/role/StockBasedCompensationTables 62 false false R63.htm 00000063 - Disclosure - Stock-Based Compensation (Details Textual) Sheet http://elitepharma.com/role/StockBasedCompensationDetailsTextual Stock-Based Compensation (Details Textual) Details http://elitepharma.com/role/StockBasedCompensationTables 63 false false R64.htm 00000064 - Disclosure - Concentrations and Credit Risk (Details) Sheet http://elitepharma.com/role/ConcentrationsAndCreditRiskDetails Concentrations and Credit Risk (Details) Details http://elitepharma.com/role/ConcentrationsAndCreditRisk 64 false false R65.htm 00000065 - Disclosure - Segment Results (Details) Sheet http://elitepharma.com/role/SegmentResultsDetails Segment Results (Details) Details http://elitepharma.com/role/SegmentResultsTables 65 false false R66.htm 00000066 - Disclosure - Segment Results (Details 1) Sheet http://elitepharma.com/role/SegmentResultsDetails1 Segment Results (Details 1) Details http://elitepharma.com/role/SegmentResultsTables 66 false false R67.htm 00000067 - Disclosure - Collaborative Agreement with Epic Pharma LLC (Details) Sheet http://elitepharma.com/role/CollaborativeAgreementWithEpicPharmaLlcDetails Collaborative Agreement with Epic Pharma LLC (Details) Details http://elitepharma.com/role/CollaborativeAgreementWithSungenPharmaLlc 67 false false R68.htm 00000068 - Disclosure - Related Party Transaction Agreements with Epic Pharma LLC (Details) Sheet http://elitepharma.com/role/RelatedPartyTransactionAgreementsWithEpicPharmaLlcDetailsTextual Related Party Transaction Agreements with Epic Pharma LLC (Details) Details 68 false false R69.htm 00000069 - Disclosure - Manufacturing, License and Development Agreements (Details) Sheet http://elitepharma.com/role/ManufacturingLicenseAndDevelopmentAgreementsDetailsTextual Manufacturing, License and Development Agreements (Details) Details http://elitepharma.com/role/ManufacturingLicenseAndDevelopmentAgreements 69 false false R70.htm 00000070 - Disclosure - Subsequent Events (Details) Sheet http://elitepharma.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://elitepharma.com/role/SubsequentEvents 70 false false All Reports Book All Reports eltp-20181231.xml eltp-20181231.xsd eltp-20181231_cal.xml eltp-20181231_def.xml eltp-20181231_lab.xml eltp-20181231_pre.xml http://xbrl.sec.gov/dei/2018-01-31 http://fasb.org/srt/2018-01-31 http://fasb.org/us-gaap/2018-01-31 true true